Evidence map›Paper›PMID 37231097›Full record

ArticleNature genetics2023

The impact of rare protein coding genetic variation on adult cognitive function.

Chia-Yen Chen, Ruoyu Tian, Tian Ge, Max Lam, Gabriela Sanchez-Andrade, Tarjinder Singh, Lea Urpa, Jimmy Z Liu, Mark Sanderson, Christine Rowley and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Nature genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The Role of SLC39A8.p.(Ala391Thr) in Schizophrenia Symptom Severity and Cognitive Ability: Cross-Sectional Studies of Schizophrenia and the General UK Population.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Journal of mood and anxiety disorders · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 4 countries.

Chia-Yen ChenResearch and Development, Biogen Inc, Cambridge, MA, USA. chiayenc@gmail.com.ORCID 0000-0001-9548-5597
Ruoyu TianResearch and Development, Biogen Inc, Cambridge, MA, USA.
Tian GePsychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
Max LamStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-4256-7844
Gabriela Sanchez-AndradeWellcome Sanger Institute, Cambridge, UK.
Tarjinder SinghStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-0601-6815
Lea UrpaInstitute for Molecular Medicine Finland, HiLIFE, University of Helsinki, Helsinki, Finland.
Jimmy Z LiuResearch and Development, Biogen Inc, Cambridge, MA, USA.ORCID 0000-0002-8379-5480
Mark SandersonWellcome Sanger Institute, Cambridge, UK.
Christine RowleyWellcome Sanger Institute, Cambridge, UK.
Holly IronfieldWellcome Sanger Institute, Cambridge, UK.
Terry FangResearch and Development, Biogen Inc, Cambridge, MA, USA.
Biogen Biobank Team
SUPER-Finland study
Northern Finland Intellectual Disability study
Mark DalyStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Aarno PalotieStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0002-2527-5874
Ellen A TsaiResearch and Development, Biogen Inc, Cambridge, MA, USA.ORCID 0000-0002-5625-1189
Hailiang HuangStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID 0000-0003-1461-5762
Matthew E HurlesWellcome Sanger Institute, Cambridge, UK.ORCID 0000-0002-2333-7015
Sebastian S GeretyWellcome Sanger Institute, Cambridge, UK.ORCID 0000-0002-6126-5040
Todd LenczDivision of Psychiatry Research, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.ORCID 0000-0001-8586-338X
Heiko RunzResearch and Development, Biogen Inc, Cambridge, MA, USA. heiko.runz@gmail.com.ORCID 0000-0002-2133-7345
University of Helsinki · FIBroad Institute · USBiogen (United States) · USUniversity of Eastern Finland · FIFinnish Institute for Health and Welfare · FIOulu University Hospital · FIWellcome Sanger Institute · GBUniversity of Turku · FITampere University Hospital · FITurku University Hospital · FIHospital District of Helsinki and Uusimaa · FIMassachusetts General Hospital · USNorthwell Health · US

Funding

Cognitive Genomics as a Window on Neurodevelopment and PsychopathologyR01MH117646 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI TODD LENCZ · 2018 to 2026
$4.7M
NIMH NIH HHS R01 MH117646Wellcome Trust
6 · The paper itself

Abstract

Compelling evidence suggests that human cognitive function is strongly influenced by genetics. Here, we conduct a large-scale exome study to examine whether rare protein-coding variants impact cognitive function in the adult population (n = 485,930). We identify eight genes (ADGRB2, KDM5B, GIGYF1, ANKRD12, SLC8A1, RC3H2, CACNA1A and BCAS3) that are associated with adult cognitive function through rare coding variants with large effects. Rare genetic architecture for cognitive function partially overlaps with that of neurodevelopmental disorders. In the case of KDM5B we show how the genetic dosage of one of these genes may determine the variability of cognitive, behavioral and molecular traits in mice and humans. We further provide evidence that rare and common variants overlap in association signals and contribute additively to cognitive function. Our study introduces the relevance of rare coding variants for cognitive function and unveils high-impact monogenic contributions to how cognitive function is distributed in the normal adult population.

Indexed as

Genetic VariationNeurodevelopmental DisordersAdultAnimalsCarrier ProteinsCognitionGenetic Predisposition to DiseaseHumansMiceNuclear ProteinsPhenotypeANKRD12 protein, humanCarrier ProteinsGIGYF1 protein, humanNuclear Proteins

Identifiers

PMID37231097
PMCPMC10260403
OpenAlexW4378212201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.